Drug
Naproxen Sodium ER (BAYH6689)
Naproxen Sodium ER (BAYH6689) is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Phase Distribution
Ph phase_1
1
17%
Ph phase_3
5
83%
Phase Distribution
1
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
5(83.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 35 (83.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Self Selection Trial of Naproxen Sodium
NCT01383486
completedphase_3
Actual Use Trial of Naproxen Sodium
NCT01427803
completedphase_3
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
NCT01389284
completedphase_3
Naproxen Sodium Extended-Release Actual Use Study
NCT00751400
completedphase_3
Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.
NCT00720057
Clinical Trials (6)
Showing 6 of 6 trials
NCT01383486Phase 3
Self Selection Trial of Naproxen Sodium
NCT01427803Phase 3
Actual Use Trial of Naproxen Sodium
NCT01389284Phase 3
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
NCT00751400Phase 3
Naproxen Sodium Extended-Release Actual Use Study
NCT00720057Phase 3
Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.
NCT00818415Phase 1
Naproxen Sodium ER Pharmacokinetic Study
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6